Combined methyl aminolevulinate-based photodynamic therapy and imiquimod in a patient with perianal extramammary Paget's disease

Photodiagnosis Photodyn Ther. 2021 Sep:35:102407. doi: 10.1016/j.pdpdt.2021.102407. Epub 2021 Jun 17.

Abstract

Extramammary Paget's disease (EMPD) is a rare form of intraepithelial adenocarcinoma. Complete surgical removal of localized disease is the standard treatment for EMPD but carries anaesthesia-related risks and possible postoperative functional deficits. Herein, we present a case of perianal EMPD successfully treated with topical methyl aminolevulinate-based photodynamic therapy (MAL-PDT), followed by topical imiquimod. Immunohistochemical analysis after PDT revealed high expression of Toll-like receptor 7 on keratinocytes, Paget's cells, and dermal inflammatory cells, as well as increased expression of intraepidermal Langerhans cells, dermal macrophages, and T cells. We propose that MAL-PDT may prime the enhancing effects of topical imiquimod. Combined local treatment with PDT and imiquimod may provide an alternative and non-invasive strategy for perianal EMPD.

Keywords: Imiquimod; Methyl aminolevulinate-based photodynamic therapy; Perianal extramammary Paget's disease; Toll-like receptor 7.

Publication types

  • Case Reports

MeSH terms

  • Aminoquinolines / therapeutic use
  • Antineoplastic Agents* / therapeutic use
  • Humans
  • Imiquimod / therapeutic use
  • Paget Disease, Extramammary* / drug therapy
  • Photochemotherapy* / methods
  • Photosensitizing Agents / therapeutic use

Substances

  • Aminoquinolines
  • Antineoplastic Agents
  • Photosensitizing Agents
  • Imiquimod